Fischer Medical Ventures
add_icon

Fischer Medical Ventures

40.45
-0.41
(-1.00%)
Market Cap
2,623.25 Cr
PE Ratio
67.88
Volume
13,15,609.00
Day High - Low
41.75 - 40.10
52W High-Low
124.70 - 32.01
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,623.25 Cr
EPS
0.08
PE Ratio
67.88
PB Ratio
7.13
Book Value
5.71
EBITDA
4.80
Dividend Yield
0.01 %
Industry
Chemicals
Return on Equity
0.36
Debt to Equity
0.21
Forecast For
Actual

Company News

View All News
Caret
neutral
Fischer Medical Ventures files SEBI SAST disclosure as promoter Shankar Varadharajan's shareholding increases to 11.46% following conversion of 60 lakh warrants worth Rs. 10.53 crores.
positive
Fischer Medical Ventures Limited announces the appointment of Mr. Balaji Gandla as Company Secretary & Compliance Officer effective March 24, 2026, following board meeting approval.
neutral
Fischer Medical Ventures Limited announces special window from February 05, 2026 to February 04, 2027 for re-lodgement of rejected physical share transfer requests in compliance with SEBI circular.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
623.50
#1 15,884.05
45.89
#1 15,112.00
-3.79
354
-228.57
41.50
984.75
12,431.27
14.16
10,355.20
17.69
#1 945
-44.09
51.81
406.30
5,970.20
9.54
8,393.40
-0.07
586
-7.98
46.20
579.55
4,256.52
-501.79
4,165.00
6.89
-65
-78.57
61.84
457.40
4,205.07
#1 8.20
3,271.20
-6.51
624
-37.05
49.64
2,100.00
4,189.46
54.70
559.90
45.35
88
-55.17
58.62
253.15
4,002.54
-13.46
4,393.10
9.61
-110
-144.26
45.83
40.45
#8 2,623.25
#6 67.88
#9 112.20
#1 421.86
#6 1
#1 6,500.00
58.84
173.20
2,087.97
-13.54
2,070.10
-1.54
-46
-10.95
46.96
142.15
1,877.79
-2,992.00
0.00
-
-0
-200.00
48.90
Growth Rate
Revenue Growth
421.86 %
Net Income Growth
-33.33 %
Cash Flow Change
-1,080.14 %
ROE
-84.14 %
ROCE
-71.21 %
EBITDA Margin (Avg.)
-60.78 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
0
0
0
21
11
40
12
49
31
89
102
Expenses
0
0
1
18
10
39
11
47
19
70
80
EBITDA
0
0
-1
3
1
1
1
3
12
19
23
Operating Profit %
0 %
0 %
-347 %
12 %
-3 %
1 %
3 %
5 %
18 %
19 %
21 %
Depreciation
0
0
0
0
0
0
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
1
1
1
Profit Before Tax
0
0
-1
3
0
0
0
2
10
17
21
Tax
0
0
0
0
0
-0
0
1
5
3
2
Net Profit
0
0
-1
3
-0
0
-0
1
5
14
19
EPS in ₹
0.00
0.00
0.00
0.48
0.65
0.05
-0.05
-0.05
0.77
0.22
0.30

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
0
86
457
Fixed Assets
0
15
24
Current Assets
0
70
365
Capital Work in Progress
0
0
1
Investments
0
1
11
Other Assets
0
70
422
Total Equity & Liabilities
0
86
457
Current Liabilities
0
4
102
Non Current Liabilities
1
1
18
Total Equity
-0
81
338
Reserve & Surplus
-0
27
244
Share Capital
0
54
64

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
1
103
Investing Activities
-29
-125
Operating Activities
-7
-87
Financing Activities
37
315

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Feb 2025
Mar 2025
Apr 2025
Jun 2025
Jul 2025
Sept 2025
Dec 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
74.91 %
74.91 %
74.91 %
74.91 %
62.81 %
62.81 %
61.80 %
61.80 %
61.80 %
61.80 %
61.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.07 %
5.07 %
5.07 %
5.07 %
5.07 %
5.06 %
5.23 %
5.38 %
5.55 %
0.00 %
5.61 %
4.85 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.68 %
1.68 %
1.68 %
1.68 %
1.68 %
1.41 %
1.44 %
1.42 %
1.42 %
0.00 %
1.42 %
1.36 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
96.72 %
96.72 %
96.61 %
94.42 %
94.38 %
94.43 %
94.43 %
94.23 %
94.20 %
99.60 %
97.60 %
97.59 %
29.75 %
29.37 %
16.47 %
16.48 %
16.39 %
16.37 %
25.30 %
26.52 %
27.48 %
26.48 %
26.47 %
26.23 %
26.14 %
Others
3.28 %
3.28 %
3.39 %
5.58 %
5.62 %
5.57 %
5.57 %
5.77 %
5.80 %
0.40 %
2.40 %
2.41 %
70.25 %
63.88 %
1.87 %
1.86 %
1.94 %
1.96 %
5.41 %
3.99 %
3.93 %
4.75 %
11.74 %
4.95 %
5.85 %
No of Share Holders
9,046
9,043
9,085
9,109
9,093
9,121
9,121
9,064
9,060
9,085
9,104
9,038
9,065
8,976
8,975
9,285
9,502
9,688
9,865
10,180
10,182
10,058
10,050
12,127
22,920

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.00

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20116 days ago
Announcement under Regulation 30 (LODR)-Allotment7 days ago
Closure of Trading Window8 days ago
Board Meeting Outcome for Appointment Of Company Secretary And Compliance OfficerMar 24, 2026
Closure of Trading WindowMar 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 12, 2026
Announcement Under Reg 30Mar 03, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Feb 06, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 06, 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJan 30, 2026
Announcement Under Reg-30Jan 30, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 30, 2026
Results- Financial Results-31/12/2025Jan 30, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30/01/2026Jan 30, 2026
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended December 31 2025 And To Transact Any Other Matter As May Be Specified In The Agenda.Jan 23, 2026
General UpdateJan 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Intimation Of Reconstitution Of Committees Of The BoardJan 02, 2026
Closure of Trading WindowDec 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 01, 2025
Clarification On Spurt On VolumeNov 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Nov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 04, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesNov 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
Update On Latest Corporate PresentationOct 30, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 29, 2025
Update On Material SubsidiaryOct 28, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 28, 2025
Results - Financial Results 30.09.2025Oct 28, 2025
Board Meeting Outcome for Board Meeting OutcomeOct 28, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Quarterly Results For The Period Ended 30.09.2025Oct 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 16, 2025
Announcement Relating To Wholly Owned SubsidiaryOct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-362
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-0.04%

Technical Indicators

RSI(14)
Neutral
60.61
ATR(14)
Less Volatile
1.92
STOCH(9,6)
Overbought
88.61
STOCH RSI(14)
Overbought
96.11
MACD(12,26)
Bullish
0.85
ADX(14)
Weak Trend
18.54
UO(9)
Bearish
72.71
ROC(12)
Uptrend And Accelerating
23.07
WillR(14)
Overbought
-15.39